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Physiological and Molecular Responses to Altered Sodium Intake in
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Markus G. Mohaupt, MD; Hiten D. Mistry, PhD, BSc;† Carine Gennari-Moser, PhD†
Background-—In pregnancy, a high plasma volume maintains uteroplacental perfusion and prevents placental ischemia, a condition
linked to elevated maternal blood pressure (BP). Reducing BP by increasing Na+ intake via plasma volume expansion appears
contra-intuitive. We hypothesize that an appropriate Na+ intake in pregnancy reduces maternal BP and adapts the renin-angiotensin
system in a pregnancy-specific manner.
Methods and Results-—BP was measured by implanted telemetry in Sprague-Dawley rats before and throughout pregnancy.
Pregnant and nonpregnant animals received either a normal-salt (0.4%; NS), high-salt (8%; HS), or low-salt (0.01%; LS) diet, or HS
(days 1–14) followed by LS (days 14–20) diet (HS/LS). Before delivery (day 20), animals were euthanized and organs collected.
Food, water, and Na+ intake were monitored in metabolic cages, and urinary creatinine and Na+ were analyzed. Na+ intake and
retention increased in pregnancy (NS, LS), leading to a positive Na+ balance (NS, LS). BP was stable during LS, but reduced in HS
conditions in pregnancy. The renin-angiotensin system was adapted as expected. Activating cleavage of a- and c-subunits of the
renal epithelial Na+ channel and expression of-full length medullary b-subunits, accentuated further in all LS conditions, were
upregulated in pregnancy.
Conclusions-—Pregnancy led to Na+ retention adapted to dietary changes. HS exposure paradoxically reduced BP. Na+ uptake
while only modestly linked to the renin-angiotensin system is enhanced in the presence of posttranslational renal epithelial Na+
channel modifications. This suggests (1) storage of Na+ in pregnancy upon HS exposure, bridging periods of LS availability;
and (2) that potentially non–renin-angiotensin–related mechanisms participate in ENaC activation and consecutive Na+ retention.
( J Am Heart Assoc. 2018;7:e008363. DOI: 10.1161/JAHA.117.008363.)
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V olume expansion prevails in pregnancy, while tightcontrol by the renin-angiotensin system (RAS) and
consecutive aldosterone production via tubular Na+ sensing1
is uncoupled in pregnancy.2–4 In pregnancy, aldosterone
levels are high despite plasma volume expansion and also less
responsive to increased Na+ intake. This volume expansion
does not translate into the expected rise in blood pressure
(BP),5 only partially explained by the aldosterone-induced
release of vasodilatory placental growth factor.6
As both high aldosterone levels and enhanced Na+ intake
have been linked to improved pregnancy outcome and
reduced BP, it is unclear whether Na+ or aldosterone is
primarily responsible.7–11 A beneficial role of an increased
Na+ uptake during pregnancy was postulated,10 yet to what
From the Departments of Nephrology and Hypertension (N.E., G.E., S.R.) and BioMedical Research (N.E., R.K., G.E., S.R., M.G.M., H.D.M., C.G.-M.), University of Bern,
Switzerland; Teaching Hospital Internal Medicine Lindenhofgruppe, Berne, Switzerland (R.K., M.G.M.); Division of Internal Medicine, University of Fribourg, Switzerland
(A.L., F.T.); Division of Child Health, Obstetrics and Gynaecology, School of Medicine, City Hospital Nottingham, Nottingham, United Kingdom (H.D.M.).
Accompanying Data S1, Tables S1 through S4 and Figures S1, S2 are available at http://jaha.ahajournals.org/content/7/15/e008363/DC1/embed/inline-
supplementary-material-1.pdf
*Dr Eisele and Dr Klossner are co–first authors.
†Dr Mistry and Dr Gennari-Moser are co–last authors.
Correspondence to: Markus G. Mohaupt, MD, Teaching Hospital Internal Medicine Lindenhofgruppe, Berne, Switzerland. Department of BioMedical Research,
University of Bern, Berne CH-3006, Switzerland. E-mail: markus.mohaupt@lindenhofgruppe.ch
Received February 15, 2018; accepted June 7, 2018.
ª 2018 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. This is an open access article under the terms of the Creative Commons
Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for
commercial purposes.
DOI: 10.1161/JAHA.117.008363 Journal of the American Heart Association 1
ORIGINAL RESEARCH
D
ow
nloaded from
 http://ahajournals.org by on Septem
ber 19, 2019
s
o
u
r
c
e
:
 
h
t
t
p
s
:
/
/
d
o
i
.
o
r
g
/
1
0
.
7
8
9
2
/
b
o
r
i
s
.
1
2
2
2
2
3
 
|
 
d
o
w
n
l
o
a
d
e
d
:
 
2
7
.
1
2
.
2
0
2
0
extent of Na+ intake remains to be elucidated. This informa-
tion is relevant to advise national health authorities as to an
appropriate Na+ intake in pregnancy,12 while lowering Na+
intake in pregnancy may even present a risk of adverse
outcomes in healthy pregnancies to mothers and to their
offspring.13,14 On the contrary, given the benefits of aldos-
terone in pregnancy, its suppression by excessive Na+ intake
might be disadvantageous.15
In preeclampsia, a frequent hypertensive disease in
pregnancy with systemic endothelial dysfunction,16,17 plasma
volume reduction precedes the clinical onset of the disease
(summarized in Luft et al18), and preventing the disease by
reducing salt intake was unsuccessful.16,19 Supporting an
increased salt intake were findings of a reduced incidence of
preeclampsia and perinatal complications as well as lower
numbers of neonatal fetal deaths in women receiving a high
Na+ diet.20 In conditions of a genetically reduced aldosterone
availability of both human pregnancy with a homozygous loss-
of-function mutant of the aldosterone synthase gene
CYP11B2 and in a knockout mouse model, increasing daily
Na+ intake led to a persistent reduction in BP and, in the
latter, to an improvement of the intrauterine growth-restricted
phenotype and placental hypoxia.8,9,11 Pharmacological inhi-
bition of aldosterone reduced umbilical perfusion in rat
fetuses.8
Effects of aldosterone on Na+ uptake are mainly
mediated via the epithelial Na+ channels (ENaCs), which
are controlled by transcriptional regulation and posttransla-
tional modifications via cleavage of inhibitory segments.21
For the latter, a role of pregnancy independent of
aldosterone is conceivable.
To elucidate the relevance of gestational Na+ intake, we
hypothesized that Na+ intake during pregnancy is linked to a
maternal BP response and that elements of the RAS are
specifically adapted to transport high amounts of Na+ in
pregnancy. We investigated the BP responses and changes
of elements of the RAS and ENaCs in pregnant and
nonpregnant rats in conditions of stable salt intake through-
out pregnancy and upon challenge with acute changes in salt
availability.
Materials and Methods
The data and analytic methods, but not study materials, will
be available to other researchers for purposes of reproducing
the results or replicating the procedure. Material is not freely
available because of the limited amounts and potential
degradation. Extended methods and materials can be found
in Data S1.
Animals
The experiments were approved by the Ethical Committee for
Animal Experiments of the Veterinary Department of the
University of Bern.
Eight-week-old female Sprague-Dawley rats (Janvier Labs,
Saint-Berthevin Cedex, France) received an implanted
telemetry device. Following 3 weeks of recovery, the estrus
cycle was verified. Day 1 of pregnancy was determined as
described earlier.22 Rats remaining nonpregnant were used
as controls.
Stable housing conditions consisted of controlled 12-hour
light cycles and temperature, with free access to chow and
water in individual cages. Before mating, rats were fed a
standard chow containing 0.4% NaCl (Kliba Nafag AG,
Kaiseraugst, Switzerland). On day 1 of pregnancy, rats were
randomly fed with either a normal-salt (NS; 0.4% NaCl), high-
salt (HS; 8% NaCl), or low-salt (LS; 0.01% NaCl) diet,
respectively. An additional group of animals (HS/LS) received
a HS diet for the first 14 days, followed by a LS diet for the
next 6 days of pregnancy. Each group consisted of 4 rats.
Nonpregnant rats were divided in similar groups, with each
group consisting of 3 rats in all but the HS group (n=5). On
day 20, animals were euthanized; blood was collected and
kidneys were weighted and stored at 70°C for further
analyses (Figure S1).
Statistical Analysis
All graphs are presented as meanstandard deviation (SD)
except for Figure S2. Daily averages of absolute BP data
obtained during either the active (nighttime) or the inactive
(daytime) phase were calculated for each individual animal
and presented following correction for baseline BP levels of
each animal individually. The weekly BP load is presented
Clinical Perspective
What Is New?
• These animal data suggest that Na+ intake is an important
environmental factor in pregnancy with a high salt intake
paradoxically associated with lower blood pressure, that Na+
is retained by posttranslational activation of Na+ transport
via the epithelial Na+ channel and stored, and that prior high
salt intake was able to bridge a consecutive period of low
salt intake by maintaining a lower blood pressure.
What Are the Clinical Implications?
• Strict Na+ restriction in pregnancy must be reconsidered;
yet as periods of lower salt intake during later stages of
pregnancy might be compensated by a higher salt intake
beforehand, the optimal Na+ intake during different stages
of gestation should be derived from observational studies.
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as area under the curve normalized for each animal’s
individual baseline except days in the metabolic cage. In
addition, daily means for each time point were tested. The
means of water and food intake is a summary of
measurements during the metabolic assessments (Data
S1). All statistical analyses for multiple comparisons were
performed using ANOVA, followed by Tukey post hoc tests
to compare all pairs of groups. With small samples sizes in
molecular analyses, the Kruskal-Wallis test was applied. In
all other analyses (nonpregnant versus pregnant) the
Student t test for unpaired comparisons was used. Blinding
was done for group allocation during analysis and for
molecular analysis except Western blotting for gel arrange-
ment. Power analysis was performed based on an earlier
paper of our group using tail-cuff measurements11 indicat-
ing a sample size per group of 3 for 90% power, which we
could slightly increase to account for an overestimated
effect size on this manual technique after discussion with
the animal ethics committee. Statistical significance was
assumed at P<0.05 and analyzed using GraphPad Prism
(version 6; GraphPad Software, USA).
Results
Effect of Na+ Intake on Weight and Water and
Food Intake
In nonpregnant animals, HS feeding led to increased water
intake (P=0.020 versus the NS group), a finding also observed
in the HS/LS group under HS (Table S1). After switching from
an HS to LS diet, water intake dropped accordingly (P=0.040
for the change of HS to LS). Weight gain did not differ
between the groups.
In pregnant rats, a similar association could be observedwith
animals on an HS diet, showing higher water intake than the
other groups. The weight gain was reduced with an altered
dietary salt intake, which was most obvious with the LS diet
(P<0.001). The short exposure to the LS diet in theHS/LS group
did not affect weight gain as compared with the HS group. If
corrected for pub number, the weight gain was highest with NS
diet similar to the absoluteweight increase. The smallest weight
rise was in the LS group (P<0.05 versus NS). The HS diet did not
show thehighestweight gain, and theHS/LSdiet tended toward
a higher weight increase than an LS diet alone. Food intake was
stable in both nonpregnant and pregnant rats, irrespective of
salt consumption, except for a reduction upon the abrupt switch
from an HS to LS diet (P=0.03) in pregnant rats.
Effect of Diet on Na+ Balance
The Na+ intake in pregnant rats fed an NS diet was higher as
compared with their nonpregnant counterparts if the whole
observation period was considered (0.1970.01 versus
0.1470.01 g/day; P=0.02) (Figure 1). No such difference
was observed for the remaining diets, while the switches to
the extremes of Na+ intake were accompanied by the
expected changes.
In nonpregnant rats, the urinary Na+ excretion remained
stable with a NS diet throughout the observational period,
whereas it initially changed as expected in the extreme
diets and remained only stable at the respective levels
thereafter. During pregnancy, urinary Na+ excretion dropped
with a NS diet from baseline (13.11.2 versus
24.13.5 mmol/mmol creatinine versus nonpregnant rats;
P=0.049). In pregnancy, Na+ excretion did not alter with HS
and HS/LS, but dropped with an LS diet (first versus
third week; P=0.031).
NS and HS diets in pregnancy led to Na+ retention
(P=0.015 and 0.014, respectively) throughout pregnancy.
With a LS diet, following an initial drop in both nonpregnant
and pregnant rats (P=0.004 and 0.0003, respectively, base-
line versus dietary week 1), they later progressively retained
salt with advancing gestational age (P=0.027 and 0.008
during weeks 2 and 3, respectively). The retention during
week 3 was completely abolished in an HS/LS diet (P<0.0001
LS versus HS/LS diet).
Effect of Na+ on BP in Nonpregnant and Pregnant
Animals
Systolic and diastolic BP was measured by telemetry,
clearly indicating a circadian rhythm (Figure 2, Figure S2).
We focused on nighttime BP measurements during active
periods of the animals, as the daytime patterns were similar
yet attenuated. As diastolic BP did not add further
information while showing a similar pattern as compared
to the systolic records, these data are not presented. After
normalization to baseline BP levels, no difference in relative
BP behavior was observed between nonpregnant and
pregnant rats fed a NS diet.
In contrast to NS, a HS diet in nonpregnant rats led to a
rise in BP within 1 week, which remained high throughout the
experiment. The BP of pregnant versus nonpregnant rats
dropped with a HS diet (combined overall P<0.0001) starting
on days 5 to 9 (P=0.004–0.044) and further reduced toward
term (P=0.013–0.031).
A LS diet did not affect the systolic BP except for a
reduction during the last 2 days of the observation in pregnant
rats (statistically significant only at day 19). Though not
reaching statistical significance, the BP tended to remain
slightly higher in pregnant as compared with nonpregnant rats
between days 5 and 9.
Applying the HS/LS diet in nonpregnant rats led to the
expected rise in systolic BP with HS followed by a drop upon
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switching to a LS diet. In pregnant animals, again a BP
reduction occurred in the HS diet, which remained stable
upon switching to a LS diet, similar to nonpregnant rats. In
pregnant animals, the BP dropped further below the
nonpregnant range only on the last experimental day.
Comparing the overall BP changes, the cumulative BP was
similar in NS, LS, and HS/LS diets irrespective of pregnancy.
In contrast, a HS diet led to lower BP in pregnancy (P=0.001).
NS HS LS HS/LS
0.000
0.002
0.004
0.006
0.15
0.20
0.25
0.30
2
4
6
8
***
Na
+
in
ta
ke
(g
/d
)
***
***
***
NS HS LS HS/LS
0.000
0.002
0.004
0.006
0.15
0.20
0.25
0.30
2
4
6
8
***
***
***
***
NS HS LS HS/LS
0
2
4
6
8
15
25
35
200
300
400 ***
Na
+
ex
cr
et
io
n
(N
a+
[m
m
ol
/L
]/
C
re
a
[m
m
ol
/L
])
***
***
***
NS HS LS HS/LS
0
2
4
6
8
15
25
35
200
300
400 ***
***
******
*
*
NS HS LS HS/LS
0
5
10
15
20
25
30
35
40
70
100
week 1 week 2 week 3before
***
*
**
*
R
at
io
of
N
a+
in
ta
ke
vs
.u
rin
ar
y
ex
cr
et
io
n
[m
g
N
a+
/(m
m
ol
N
a+
/m
m
ol
C
re
a)
]
***
**
NS HS LS HS/LS
0
5
10
15
20
25
30
35
40
70
100 ***
*** ***
*
* *
***
*
**
***
Nonpregnant Pregnant
A
B
C
Figure 1. Metabolic Na+ steady state of nonpregnant and pregnant rats. In both groups, high-salt (HS) and low-salt (LS) diet led to
increased and decreased Na+ intake (A) and excretion (B), respectively. In the group being switched from HS to LS diet, patterns similar to
the individual dietary changes were observed. In addition, in normal salt (NS) conditions, pregnant rats decreased their Na+ excretion
along pregnancy. C, Na+ balance as ratio of Na+ intake over urinary excretion rose in pregnant animals provided with either an NS or an
HS diet rose, indicating Na+ retention. While nonpregnant rats undergoing an LS diet did not retain Na+, pregnant animals progressively
retained it, reaching a maximum at week 3. This response to LS was absent in the HS/LS group. The time periods are indicated
as before mating (baseline [white]), weeks 1, 2, and 3 (light gray, dark gray, and black bar, respectively) (n=4 for pregnant rats; n=3–5 for
nonpregnant rats). Data are presented as meanSD and tabulated in Table S4. *P<0.05, **P<0.01, ***P<0.001.
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Effect of Na+ on the BP Area Under the Curve
Between Nonpregnant and Pregnant Animals
Within Individual Dietary Interventions
Weekly changes in systolic BP indicated as area under the
curve individually normalized for each animal showed in
nonpregnant rats on an HS diet an increased BP (P<0.05
versus LS) (Figure 3). The BP in the LS and NS groups were
similar. In the HS/LS group, the BP dropped with LS
(P<0.01).
In pregnant rats, BP tended to rise with LS and drop with
HS (P=0.0108 versus NS) but fell in both of these diets and
also with HS/LS toward the third gestational week. The latter
resembled the HS pattern and is different from those animals
continuously having been exposed to the LS diet.
Expression of Elements of the Renal RAS System
in Pregnant and Nonpregnant Rats
Angiotensinogen transcripts were more prominently
expressed in the renal medulla as compared with the cortex
with a tendency to similar or slightly higher levels in pregnant
rats (Figure 4, Table S2). Cortical angiotensin-converting
enzyme mRNA expression was lower in pregnant rats with
NS intake. A comparable relationship was seen in the medulla
with a HS intake. In contrast, a HS followed by a LS intake led
to a distinct upregulation of angiotensin-converting enzyme.
As expected, renin expression was low with HS and high with
LS intake. The angiotensin receptor subtypes 1a and 1b had
lower expression in pregnancy except for the medullary
expression of the 1b subtype.
-2 -1 1 2 5 6 7 8 9 12 13 14 15 18 19
70
80
90
100
110
non-pregnant
pregnant
Days
S
ys
to
lic
bl
oo
d
pr
e s
su
re
[%
of
ba
se
lin
e]
-2 -1 1 2 5 6 7 8 9 12 13 14 15 18 19
70
80
90
100
110
non-pregnant
*
*
**
pregnant
*
***
Days
S
ys
to
lic
bl
oo
d
pr
es
su
re
[%
of
ba
se
lin
e]
-2 -1 1 2 5 6 7 8 9 12 13 14 15 18 19
70
80
90
100
110
non-pregnant
pregnant
*
Days
S
ys
to
lic
b l
o o
d
pr
e s
su
re
[ %
of
ba
se
lin
e ]
-2 -1 1 2 5 6 7 8 9 12 13 14 15 18 19
70
80
90
100
110
non-pregnant
pregnant
* * *
*
**
*
Days
S
ys
to
lic
bl
oo
d
pr
es
su
re
[ %
of
ba
se
lin
e]
Normal salt (NS) diet High salt (HS) diet
Low salt (LS) diet High/Low salt (HS/LS) diet
HS LS
A B
C D
Night (active)
Figure 2. Normalized systolic blood pressure (BP) (%) during night activity is given in nonpregnant (white symbol, dashed line) and pregnant
(black symbols, continuous line) during normal-salt (NS; A), high-salt (HS; B), low-salt (LS; C) and HS/LS diet (D; dietary change indicated by the
vertical line). Days with metabolic assessment without telemetry are indicated by gray bars. While HS diet increased BP in nonpregnant rats, it
was associated with a BP drop in pregnant rats. This drop was present during only the last 2 days of observation in pregnant animals on an LS
diet. The group with the dietary change demonstrated a drop for both nonpregnant and pregnant rats upon introduction of the LS diet, but the
effect was more intense in pregnant rats (n=4 for pregnant rats; n=3–5 for non-pregnant rats). Data are presented as meanSD and tabulated in
Table S4. *P<0.05, **P<0.01.
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Adjustments of Elements of Aldosterone-
Dependent Na+ Transport in Pregnant Rats
While ENaC-a subunit mRNA levels were not remarkably
regulated, -b and -c subunits showed a high expression in HS
conditions in the nonpregnant rat (Figures 5 and 6, Table S3).
In pregnant animals, this change was absent and the overall
transcript amount was lower.
As ENaC-a and -c subunits are activated by cleavage, both
full-length and cleaved subunits were determined. The highest
expression of full-length proteins was in HS/LS conditions in
both groups in the renal cortex, but not in medullary tissue. In
nonpregnant, in contrast to pregnant rats, ENaC-a abundantly
appeared in its cleaved form in the renal cortex in LS and even
stronger in HS/LS conditions. Medullary samples showed no
gestational specificity, yet a high expression in pregnancy.
Cortical ENaC-b protein expression only mildly increased in
pregnant rats exposed to the HS/LS challenge. In contrast,
the ENaC-b subunit protein strongly increased (P=0.0062) in
the medulla in pregnancy independent of diet. This was
paralleled for the full-length ENaC-c subunit with an increase
in medullary tissue only with pregnancy. As expected in the
nonpregnant setting, the cleaved c-subunit was more abun-
dant in cortical tissue in LS conditions, yet reversed in
pregnancy and unchanged in the medulla.
Discussion
We investigated Na+ handling in nonpregnant and pregnant rats
exposed to extremes of Na+ intake, or rapid changes of Na+
availability. The Na+ intakewas higher in pregnant animals in NS
conditions resembling human behavior.10 No such differences
regarding the Na+ intake were present for the other diets.
During pregnancy, Na+ appears to be retained progressively,
most obviously in LS conditions, and more rigorously than in
nonpregnant rats, as shown by Na+ excretion. The Na+ balance
revealed Na+ retention in all conditions, with striking differ-
ences during the last week of LS intake in pregnant as
compared with nonpregnant animals. Surprisingly, a prior HS
converted pregnant animals with the switch to LS to behave as
LS animals in nonpregnant conditions, suggesting a profound
Na+ storage earlier during the preceding HS period. While
nonpregnant HS rats tended to increase their BP, pregnant ones
demonstrated a reduced BP. These findings in a rat model
confirm our recent observations in pregnant women10 in a
model with accurate Na+ balance.
A prior HS diet in those pregnant animals chosen to switch to
a LS diet after 2 weeks of pregnancy abolished the BP drop
seen with HS during the third gestational week, whereas a LS
diet alone had no such effect. These observations strongly
suggest a mechanism permitting BP lowering with a HS diet in
pregnancy, which occurs in association with the pronounced
Na+ retention. This Na+ retention may even outlast periods of
low Na+ availability such as is simulated in our HS/LS switch
group. With respect to the expected changes of the renal RAS
system, including the angiotensin receptor subtype 1, only mild
responses occurred because of pregnancy. Of interest, the high
renin state of pregnancy was not reflected by the intrarenal
transcript levels. Likewise, expression of ENaC subunits as Na+
transporters was unchanged or rather low. The medullary
expression of the active cleaved ENaC-a and b subunits was
very strong in pregnancy, suggesting a facilitated Na+ transport.
Although the medullary full-length ENaC-c subunit was also
highly expressed, the cleaved form was low.
Changes in Na+ intake during pregnancy have been studied
in many models. As suggested by findings in humans, a diet
reduced in Na+ content does not improve the clinical course
of pathological pregnancies.13,19 This was supported by
observations in animal experiments, where either a low-Na+
diet or low-aldosterone conditions caused by chronic
A
B
Figure 3. The change of the normalized area under the curve
(AUC) of systolic blood pressure (BP) to baseline (%) during night
activity is given in nonpregnant (A) and pregnant rats (B) at
baseline (white), during weeks 1 and 2 (light gray bar), and on
week 3 (dark gray bar). The respective diet is indicated on the x
axis. While rats on a normal-salt (NS) diet behaved similarly, those
on a high-salt (HS) diet showed a divergent response, with
nonpregnant rats increasing their BP load and pregnant rats
reducing their BP load (P<0.001). The pregnant animals on low
salt (LS) first suffered an increase, yet later a slight but consistent
drop in BP load. Of interest, nonpregnant rats with the dietary
change HS/LS reduced their BP load strikingly, whereas pregnant
HS/LS rats behaved as HS animals irrespective of the switch to
LS in the third week of pregnancy (n=4 for pregnant rats; n=3–5
for nonpregnant rats). Data are presented as meanSD and
tabulated in Table S4. *P<0.05, **P<0.01.
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Figure 4. Expression of components of the renin-angiotensin system (RAS) as assessed by
TaqMan polymerase chain reaction. The expression of angiotensinogen (A, upper panel),
angiotensin converting enzyme (ACE; B, middle panel), renin (C, lower panel) and angiotensin II
receptor subtype 1a (D, upper panel) and 1b (E, lower panel) is given in nonpregnant (left-hand
columns) and pregnant rats (right-hand columns) at baseline (white), during weeks 1 and 2 (light
gray bar), and on week 3 (dark gray bar) in renal cortex (left panel) and renal medulla (right panel)
separately. A low-salt (LS) diet rather increased renal angiotensinogen expression in pregnancy.
In pregnancy, a high-salt (HS)/LS diet led to the highest renin expression in pregnancy, while the
response was reverse in nonpregnant animals. Renin expression was regulated as physiolog-
ically expected (lower panel) (n=4 for pregnant rats; n=3–5 for nonpregnant rats). Data are
presented as meanSD and tabulated in Table S4. *P<0.05, **P<0.01.
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spironolactone treatment as well as aldosterone synthase
knockout led to reduced umbilical perfusion and/or intrauter-
ine growth restriction.8,11,23
Pregnant NS rats increased Na+ intake while excretion
dropped as pregnancy progressed, suggesting an absolute Na+
retention, a finding that has recently been attributed to the renal
ENaC in the late normal pregnant rat.24 The enhanced sponta-
neous Na+ intake is again in line with findings by our group in
humanpregnancy.10AlthoughexposedtoanexcessiveNa+ load,
even pregnant animals of the HS group overall retained Na+.
Such a paradox in salt handling in pregnancy underlines the
assumption that aldosterone and Na+ regulation are (at least
partially) uncoupled in pregnancy. Stimulation of aldosterone
production by pregnancy-derived angiogenic signals is well
conceivable as a contributor of aldosterone stimulation inde-
pendent of the RAS.4 The salt retention is extreme during LS
conditions inpregnancy, indicatingahighlycapablemechanism.
As the RAS, in part, even in pregnancy contributes to
aldosterone production and volume regulation, we aimed to
challenge this system by first providing large amounts of Na+
and, upon perfusion of the rat placenta beyond day 14 of
gestation, to abruptly switch to a LS diet. This challenge did not
A
B
C
Figure 5. Expression of epithelial Na+ channel (ENaC) subunit transcripts as assessed by TaqMan
polymerase chain reaction. The expression of the ENaC a- (A, upper panel), b- (B, middle panel), and c-
subunit (C, lower panel) is given in nonpregnant (left-hand columns) and pregnant rats (right-hand columns)
at baseline (white), during weeks 1 and 2 (light gray bar), and on week 3 (dark gray bar) in renal cortex (left
panel) and renal medulla (right panel) separately ENaC-a subunit mRNA levels were not remarkably
regulated. In contrast, ENaC-b and -c subunits show a high expression in high-salt (HS) conditions in the
nonpregnant rat, while this change was absent in pregnant animals with the overall transcript amount being
also lower (n=4 for pregnant rats; n=3–5 for nonpregnant rats). Data are presented as meanSD and
tabulated in Table S4. *P<0.05, **P<0.01. HS indicates high-salt; HS/LS, HS followed by LS; LS, low-salt;
NS, normal-salt.
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produce the expected LS Na+ retention phenotype in pregnant
rats but paralleled the pattern seen in nonpregnant rats. This
suggests that prior Na+ retention during the HS diet supplied
sufficient residual Na+ or an inability of the animals to rapidly
adapt to the environmental change. This is interesting because
the HS/LS group was considered to be extremely challenged by
first a suppression of aldosteronewith theHS diet, followed by a
marginal salt availability only at times of placental perfusion and
required plasma volume expansion. Our observation of the
importance of an HS diet is highlighted in contrast to earlier
findings, in which a limited exposure to a LS diet during the last
week of gestation not preceded by a HS phase resulted in
similar changes as compared with a LS diet throughout
pregnancy.23,25 Given the highest and lowest weight gain with
NS and LS diets, respectively, and not with the HS and HS/LS
challenge, indicates a more complex issue of time and optimal
dosing of salt intake during pregnancy.
Contrary to LS, the extreme HS diet led to decreased BP in
pregnant rats. It was accentuated in late pregnancy after
gestational day 14, when the plasma volume usually increases
Figure 6. Expression of ENaC subunit protein as assessed by Western blot analysis. The expression of the ENaC a-subunit (A,
upper panel, full-length protein; lower panel, cleaved protein), b-subunit (B, full-length protein), and c-subunit (C, upper panel,
full-length protein; lower panel, cleaved protein) is given in nonpregnant (left-hand columns) and pregnant rats (right-hand
columns) at baseline, during weeks 1 and 2, and on week 3 (white, light gray, and dark gray bars, respectively) in renal cortex
(left panel) and renal medulla (right panel) separately. Full-length transcripts were highest expressed in low-salt (LS) conditions
following a high-salt (HS) exposure in both nonpregnant and pregnant rats in the renal cortex, yet not in medullary tissue. In
contrast to pregnant rats, in nonpregnant rats, in LS and even stronger in HS/LS conditions, ENaC-a abundantly appeared in its
cleaved form in the renal cortex. Both nonpregnant and pregnant animals showed a similar pattern in medullary samples, though
the expression levels in pregnancy were hugely elevated (A). Cortical ENaC-b protein expression only mildly increased in
pregnant rats exposed to the HS/LS challenge. A huge increase was observed in the medulla with pregnancy for the ENaC-b
subunit protein for all diets (B). A similar picture was experienced for the full-length ENaC-c subunit with an increase in medullary
tissue only with pregnancy (C). As expected in the nonpregnant setting, the cleaved c-subunit was more abundant in cortical
tissue in LS conditions and reversed with pregnancy, yet unchanged in the medulla (n=3 for each group). Data are presented as
meanSD and tabulated in Table S4. *P<0.05, **P<0.01, ***P<0.001. HS indicates high-salt; HS/LS, HS followed by LS; LS,
low-salt; NS, normal-salt.
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Figure 6. Continued
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in rat pregnancies.26 This observation is in line with findings in
mice with a less stringent HS diet, in which fetal growth and
placental hypoxia were improved without increasing maternal
BP.11 Furthermore, our results indicate an inverse relationship
between BP and Na+ intake, in line with our previous results in
first-trimester pregnant women, where HS intake was related
to lower BP levels.10
The changes toward a higher expression of ENaC subunits
and a more pronounced cleavage with enhanced activity
resemble ENaC expressional changes observed in nephrotic
syndrome, where plasmin appears to have a causative role in
activating the ENaC.27 Given the high levels of plasminogen
activator inhibitor-1 and -2 levels in pregnancy, other serine
proteases might be involved. In humans, urinary exosomes
show an enhanced ENaC expression and also processing by
cleavage.28 Interfering with the RAS toward a higher aldos-
terone level by a LS diet or direct aldosterone infusion also
enhanced ENaC-a and -c subunit exosomal excretion in
humans.29 Although ENaC mRNA levels were unable to exactly
predict active ENaC protein abundance, blocking ENaC
expression could not be compensated for in late pregnant
rats.24 Thus, ENaC appears to be a central element in Na+
regulation in pregnancy. Although its transcript regulation is
mediated via aldosterone,30 further activating modifications
are due to protein-cleaving conditions.
The strength of our study was the use of a telemetry
device as well as detailed and controlled metabolic analysis
of the Na+ balance. In addition, the dietary changes were
major, in contrast to other studies in pregnancy, and not
limited to the final phase of the pregnancy. Given the
dynamic adaptation throughout pregnancy, such a study
might be difficult to interpret.31 In that study, a late dietary
adjustment was made limited to the third trimester of rat
pregnancy. As BP reduction was present only after some
latency in our model, which we started at gestation, a
delayed intermediary response is likely involved. This could
indicate that sensing and adaptation to a higher-than-NS
intake might require exposure during earlier phases of
pregnancy or may simply require time. In line with these
considerations are studies by Machnik et al,32 who describe
the skin as a relevant storage and regulatory compartment
in response to Na+.
A limitation of this study is the small number of animals
attributable to the extended experimental setup. Furthermore,
a broader dosage range should be investigated in further
studies to identify an optimal Na+ intake as well as the
optimal times to eventually alter the salt regimen in a less
extreme condition, combined with an analysis of Na+ storage
such as has been otherwise identified in the skin.32
In conclusion, to date, only limited information is available
in human pregnancy, suggesting clear positive effects of
increasing salt intake, such as in genetic aldosterone
synthase deficiency and in the first trimester of healthy
women.9,10 The current study in rats provides further insight
with respect to increasing salt intake in pregnancy. Although
the sensitive balance between Na+ and aldosterone as well as
placental development requires further attention and studies
to optimize the dosing and perhaps timing of salt delivery, this
study contributes to better comprehension the impact of Na+
availability in pregnancy beyond its impact on the RAS.
Coexisting conditions leading to an activation of ENaC might
contribute or even abolish functional activating pathways
such as with increased plasminogen activator inhibitor-1
levels.33
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Supplemental Methods  
Implantation of telemetry, BP measurement and metabolic cages 
BP telemetry devices, TA11PA-C40 (Data Science International, St Paul, MN, USA), 
were implanted as previously described (1) in the abdominal aorta of the rats. In short, 
following midline abdominal incision, the aorta was prepared and punctured just above 
the bifurcation using a 23-gauche needle for insertion of the telemetry catheter. After 
sealing (Vetbond 3M, Aichele Medico, Aesch, Switzerland) and control of the catheter 
placement, the device battery was attached to the left lateral abdominal wall and the skin 
closed. The data (systolic and diastolic BP) were transmitted to a receiver and collected 
for 10s, every 15min (Fig. S2).  
After 3w of recovery, the animals were transferred to metabolic cages for approximately 
30h before mating and at days 3 to 4 (week 1), 10 to 11 (week 2), and 16 to 17 (week 3) 
of pregnancy. A second cohort of non-pregnant rats was placed in metabolic cage at the 
same time points. Urine was collected and food/water intake was monitored. Telemetric 
BP recordings were obtained for 3d before mating and throughout pregnancy when the 
animals were returned to their original cage.  
 
Urine analysis 
Urinary creatinine and Na+ excretion were determined in our central hospital 
laboratories using validated routine clinical methods. Na+ balance was calculated as the 
ratio of Na+ intake vs. urinary Na+ excretion, A high ratio thus indicates a Na+ retention. 
  
RNA extraction and TaqMan PCR analysis of components of the RAS in the renal cortex 
and medulla 
Independent frozen kidney specimens (n=3 animals) were pulverized in liquid nitrogen 
and homogenized by ultrasonic homogenizer (20s) with RNA being extracted using the 
SV total RNA isolation kit or by the Trizol method. Using 2ug of RNA, reverse 
transcription using the Super Script III RT-PCR system was completed (Invitrogen, 
USA). Homology-based quantitative TaqMan PCR was performed with Roche 
Universal Probe Library primers and probes for angiotensinogen, angiotensin 
converting enzyme, renin, angiotensin receptor 1a and 1b, and the ENaC subunits α, β 
and γ to identify and quantify the respective transcripts. Negative controls for the RT 
and the PCR reagents were assessed. The geometric mean of β-actin, HPRT1 and Hmbs 
served as endogenous controls (Supplemental Table S2). Each measurement was 
repeated in triplicates. 
 
Sample preparation for Western blot analysis  
Independent plasma membrane fractions (n=3 animals) were prepared of cortical and 
medullary renal specimens. The frozen kidney specimens were pulverized in liquid 
nitrogen and homogenized by ultrasonic homogenizer (20s) in ice-cold homogenisation 
buffer containing 250mmol/L sucrose, 10mmol/L triethanolamine, 10mmol/L Na+-
pyrophosphate, 1mmol/L Na+-orthovanadate, 100mmol/L Na+-fluoride, 1.3mg/10μl 
DMSO of N-ethilaleimide and one tablet of complete protease inhibitor cocktail per 2ml 
(Roche, Grenzach-Wyhlen, Germany). The homogenate was centrifuged at 1,000g and 
4°C for 5min and the supernatant was further centrifuged at 20,000g and 4°C for 60min 
to obtain a fraction enriched for plasma membranes. The pellet was resuspended in 
sucrose buffer containing phosphatase and protease inhibitors. 
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All protein concentrations from kidney cortex and medulla homogenates were 
determined using a colorimetric protein assay based on the biuret reaction (Pierce, BCA 
Protein Assay Kit, Thermo Scientific, Switzerland), using an albumin standard to 
establish a linear calibration curve. 
 
SDS-Polyacrylamide gel electrophoresis (SDS-PAGE) and immunoblotting  
The protein separation was performed by the SDS-Page method in an electrophoresis 
chamber (Biorad, California, USA) using an electrophoresis buffer consisting of 1% 
SDS, 192mmol/L glycine and 25mmol/L Tris at pH 8.3. The samples were dissolved in 
Laemmli buffer (3% SDS, 10% glycerol, 5% mercaptoethanol, 1% bromophenol blue, 
95mmol/L Tris [pH 6.8]), denatured for 5min at 95°C, and loaded on 10% or 12% 
acrylamide gels. The molecular weight was determined with Page Ruler Plus prestained 
protein ladder (Thermo Fisher Scientific Inc., USA). The protein was transferred from 
the gel to a nitrocellulose membrane (Brunschwig, The Netherlands) with a tank-
sandwich Western blotting system under permanent cooling conditions. Equal loading 
and electrophoretic transfer quality of the proteins onto nitrocellulose membranes were 
verified using 0.1% Ponceau red staining. Membranes were blocked with 5% skim milk 
for 60min and then incubated overnight at 4°C with primary antibodies. Thereafter, 
membranes were extensively washed with 0.5% Tween/TBS solution and incubated 
with secondary antibodies for 2h. Immunoreactive bands were detected using an 
enhanced chemiluminescence kit (Amersham ECL Select Western Blotting Detection 
Reagent, GE Healthcare, UK) followed by subsequent acquisition using Syngene G:Box 
Chemi XX6 software (Cambridge, UK). Band intensity was evaluated using Image J 
and normalized to β-actin abundance with control values set as 100%. Each 
measurement was repeated in triplicates. 
For Western blot previously well-characterized primary antibodies were used: The non-
commercial polyclonal, anti-rabbit antibodies against full length α-subunits of ENaC 
(1:500 (2)), against a synthetic peptide mapping to the N-terminal amino acids 46-68 
(StressMarq Biosciences Inc., Victoria BC CANADA, catalogue # SPC-403; 1:500), 
against β-subunits of ENaC (1:500 (2)), against γ-subunits of ENaC (1:500 (2)), and 
against β-actin (Santa Cruz Biotechnology, Inc., USA; 1:2000). As secondary antibody 
was used HRP-conjugated affinity purified donkey anti-rabbit IgG (Jackson 
ImmunoResearch Laboratory Europe Ltd., UK; 1:5,000). 
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Table S1. Impact of salt intake on body weight, food and water consumption in 
non-pregnant (n=3-5) and pregnant (n=4) rats. 
   
Non-pregnant 
 
  
  
NS HS LS 
HS/LS 
HS LS 
Weight gain (day 20)  
[% of initial body weight] 14.0± 4.0 14.7± 1.3  8.9± 7.6                                  10.8± 6.6 
Water intake  
[ml/100g BW/d] 12.0± 5.2  26.5± 1.5* 15.9±12.5 26.5±1.8*  10.4± 9.8§ 
Food intake  
[g/100g BW/d] 11.5± 0.6 14.0± 1.1 12.6± 0.9 13.2±1.7 11.9± 1.2 
            
   Pregnant   
 
    
  
  
NS HS LS 
HS/LS 
HS LS 
Weight gain (day 20)  
[% of initial body weight] 45.7±11.8 30.1±11.7* 18.5± 9.3***                                  28.9± 6.4*
Weight gain (day 20) 
[% of initial body weight/fetus] 2.0± 0.9  1.4±1.4   0.8± 0.9*   1.2± 0.5 
Water intake  
[ml/100g BW/d] 15.9± 9.4 29.6± 3.7** 22.7± 5.2 32.0±5.4*** 19.6± 6.2§ 
Food intake 
[g/100g BW/d] 14.1± 2.8 12.0± 2.0 13.0± 0.8 12.7±1.4  10.2± 0.9** 
 
Results in mean ± SD  *P<0.05  **P<0.001  *** P< 0.0001 vs. NS 
    §P<0.05 between the switch of salt diet (HS to LS) 
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Table S2. Mean absolute expression levels of components of the RAS as assessed 
by TaqMan PCR (average Ct values). 
Gene Cortex Medulla 
Angiotensinogen 30 29 
ACE 28 27 
Renin 25 26 
Angiotensin receptor 
subtype 1a 29 28 
Angiotensin receptor 
subtype 1b 32 32 
ENaC-α 26 28 
ENaC-β 28 28 
ENaC-γ 31 33 
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Table S3. Primers used in real-time PCR. 
Gene Accession number Primers Probe 
Amplicon size 
(nt) 
          
     
Angiotensinogen NM_134432.2 5'- GAT AAA GAA CCC GCC TCC TC -3’ 62 117 
  5'- GCA CCC AAA AGG GTA GAC AG -3’   
     
ACE NM_012544.1 5'- CCA ACA TCA CGG AGG AGA AT -3’ 1 69 
  5'- CCT CTG CAA ACT CCT GGT TG -3’   
     
Renin NM_012642.4 5'- TGT AGC TTC AGT CTC CCG ACA -3’  76 66 
  5'- CGA GGG CAT TTT CTT GAG C -3’   
     
AGTR1a NM_030985.4 5'- CAC CCG ATC ACC GAT CAC -3’  53 110 
  5'- CAG CCA TTT TAT ACC AAT CTC TCA -3’   
     
AGTR1b NM_031009.2 5'- GAC ACA CAC AGC CTT TCC AG -3’  49 113 
  5'- GCT CTC TGA CAC TAT TTA AAA TGC AC -3’   
     
ENaC-α  NM_031548.2 5'- CCA AGG GAG TTG AGT TCT GTG -3’ 128 75 
  5'- AGG CGC CCT GCA GTT TAT -3’   
     
ENaC-β  NM_012648.1 5'- GGC ATG ACA GAG AAG GCA CT -3’  95 77 
  5'- TGA CCA ATG TCC AGG ATC AA -3’   
     
ENaC-γ NM_017046.1 5'- CTA CAC ATT TAA CAA CAA AGA AAA TGC -3’  73 94 
  5'- TTC GTT TAT GTA TAA GAT GAC TTG CAG -3’   
     
β-actin NM_031144.2 5'- CCC GCG AGT ACA ACC TTC T -3’  17 72 
  5'- CGT CAT CCA TGG CGA ACT -3’   
     
HPRT1 NM_012583.2 5'- GGT CCA TTC CTA TGA CTG TAG ATT TT -3’  22 126 
  5'- CAA TCA AGA CGT TCT TTC CAG TT -3’   
     
Hmbs NM_013168.2 5'- TCC CTG AAG GAT GTG CCT AC -3’  79 73 
  5'- AAG GGT TTT CCC GTT TGC -3’   
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Table S4. Numerical data of figures. 
To figure 1A 
Na+ intake [g/d] 
  Before Week 1 Week 2 Week 3 
Nonpregnan
t 
NS 0.15±0.0
1 
0.17±0.0
5 
0.12±0.0
1 
0.14±0.0
1 
 HS 0.20±0.0
2 
3.25±1.1
0 
3.58±1.2
8 
3.48±1.8
7 
 LS 0.15±0.0
5 
0.00±0.0
0 
0.00±0.0
0 
0.00±0.0
0 
 HS/L
S 
0.20±0.0
5 
3.63±1.1
4 
3.81±1.7
6 
0.00±0.0
0 
Pregnant NS 0.17±0.0
4 
0.23±0.0
6 
0.17±0.1
0 
0.19±0.1
0 
 HS 0.13±0.0
1 
3.42±0.3
9 
2.42±0.7
6 
2.88±0.4
9 
 LS 0.14±0.0
3 
0.00±0.0
0 
0.00±0.0
0 
0.00±0.0
0 
 HS/L
S 
0.17±0.0
3 
3.48±0.3
1 
2.70±0.4
0 
0.00±0.0
0 
 
To figure 1B 
Urinary Na+ excretion [mmol/mmol creatinine] 
  Before Week 1 Week 2 Week 3 
Nonpregnant NS  15±  2  15±  3  13±  3  13±  2 
 HS  19±  4 237± 45 279± 79 255±131 
 LS  18±  4   3±  1   1±  0   3±  1 
 HS/LS  22±  4 220± 48 285± 19   5±  5 
Pregnant NS  24±  7  15±  2  13±  7  11±  3 
 HS  19±  6 303± 24 174± 79 282± 67 
 LS  18±  2   4±  2   1±  1   0±  0 
 HS/LS  17±  5 314± 36 199± 26   2±  2 
 
To figure 1C 
Na+ intake/urinary Na+ excretion [(mg Na+)/(mmol Na+/mmol creatinine)] 
  Before Week 1 Week 2 Week 3 
Nonpregnant NS 10.3± 1.6 11.5± 1.6  9.8± 0.9 10.8± 2.4 
 HS 10.9± 2.8 14.3± 6.1 13.5± 5.2 13.6± 0.3 
 LS  8.7± 1.2  1.6± 0.7  2.6± 0.8  1.4± 0.3 
 HS/LS  9.8± 2.8 17.2± 6.4 13.2± 5.2  4.0± 3.3 
Pregnant NS  7.9± 3.4 15.0± 5.3 16.6± 7.9 15.7± 4.6 
 HS  7.4± 2.5 11.3± 1.5 14.9± 4.0 10.4± 1.4 
 LS  7.5± 0.7  1.6± 1.0  4.2± 2.2 38.6±31.9 
 HS/LS 10.3± 3.0 11.2± 1.4 13.9± 3.5  2.9± 2.4 
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To figures 2A-D 
Systolic blood pressure [% of baseline] 
 Day NS HS LS HS/LS 
Nonpregnant -2 100± 3 100± 3 101± 4 100± 3 
 -1 100± 8 100± 3  99± 5 100± 3 
 01 102± 6 101± 1 103± 5 101± 1 
 02 103± 6 104± 3 102± 3 104± 3 
 05 103± 7 108± 3 102±10 108± 3 
 06 104± 4 107± 5 102± 7 107± 5 
 07 103± 4 108± 6 101± 7 108± 6 
 08 103± 5 107± 6  98± 5 107± 6 
 09 100± 4 106± 3 100± 6 106± 3 
 12 103± 3 104±11 102± 8 104±11 
 13  99± 2 103± 6 105± 6 103± 6 
 14 101± 2 100± 7 102± 4 103± 6 
 15 102± 1 107± 6 100± 4  92± 6 
 18 102± 2 106± 1 104± 8  91± 7 
 19  99± 2 106± 6 102± 6  92± 5 
Pregnant -2 100± 3 100± 4 101±10 100± 4 
 -1 100± 2 100± 7 100±12 100± 7 
 01 101± 6 98±10 101±12  98±10 
 02 102± 5 100±10 100± 8 100±10 
 05 103± 4 100± 6 106± 8 100± 9 
 06 103± 3  99± 7 104± 7  99± 7 
 07 103± 2 100± 9 104± 4 100± 9 
 08 103± 4  95±12 103± 7  95±12 
 09 102± 8  95± 8 103± 8  95± 8 
 12 102± 4  96± 7 104±10  96± 7 
 13 103± 7  99± 3 101± 7  99± 3 
 14 104± 6  97± 7 100± 5  97± 7 
 15 103± 5  96± 9 103± 6  92± 4 
 18 101± 4  89± 8  97±11  93± 6 
 19  99± 5  84±11  90± 5  85± 5 
 
To figures 3A-B 
Change of normalized AUC of systolic blood pressure [% of baseline] 
  Before Week 1+2 Week 3 
Nonpregnant NS 0.0±0.0  2.6±2.1  1.5±5.6 
 HS 0.0±0.0  5.9±3.1  4.6±7.4 
 LS 0.0±0.0  1.2±1.9  1.9±1.7 
 HS/LS 0.0±0.0  4.9±2.6 -7.2±8.2 
     
Pregnant NS 0.0±0.0  2.5±4.8  1.8±4.1 
 HS 0.0±0.0 -2.1±4.4 -7.5±5.1 
 LS 0.0±0.0  2.6±3.1 -2.0±5.4 
 HS/LS 0.0±0.0 -1.6±2.5 -8.6±2.9 
 
To figures 4A-E 
D
ow
nloaded from
 http://ahajournals.org by on Septem
ber 19, 2019
 
mRNA [relative expression] 
  NS HS LS HS/LS 
Angiotensinogen C-NP 1.0±0.2 1.3±0.1 0.5±0.1 0.7±0.2 
 C-P 1.0±0.2 1.0±0.3 1.1±0.2 0.7±0.1 
 M-
NP 
1.0±0.3 1.6±0.3 1.1±0.6 0.6±0.2 
 M-P 1.4±0.1 1.7±0.4 1.8±0.4 1.6±0.1 
ACE C-NP 1.0±0.2 0.8±0.1 0.8±0.1 0.5±0.2 
 C-P 0.2±0.1 0.5±0.2 0.5±0.1 0.7±0.1 
 M-
NP 
1.0±0.3 1.4±0.1 1.0±0.4 0.5±0.2 
 M-P 0.4±0.1 0.8±0.1 0.9±0.2 1.6±0.1 
Renin C-NP 1.0±0.5 0.3±0.1 1.0±0.5 0.5±0.1 
 C-P 1.0±0.5 0.3±0.1 2.0±0.3 1.1±0.4 
 M-
NP 
1.0±0.3 0.2±0.2 1.1±0.3 0.2±0.1 
 M-P 0.2±0.1 0.3±0.1 0.6±0.2 0.3±0.1 
AGTR1a C-NP 1.0±0.2 1.2±0.1 0.6±0.1 0.7±0.1 
 C-P 0.9±0.3 0.5±0.2 0.5±0.1 0.4±0.1 
 M-
NP 
1.0±0.2 1.8±0.2 0.7±0.1 1.0±0.1 
 M-P 0.8±0.2 1.2±0.2 0.4±0.1 0.5±0.1 
AGTR1b C-NP 1.0±0.2 0.9±0.1 0.8±0.2 1.0±0.2 
 C-P 0.9±0.5 0.5±0.2 0.6±0.2 0.4±0.1 
 M-
NP 
1.0±0.3 1.2±0.1 1.0±0.2 1.0±0.3 
 M-P 0.8±0.3 1.7±0.4 0.6±0.3 0.5±0.2 
 
To figure 5 
mRNA [relative expression] 
  NS HS LS HS/LS 
ENaC-α C-NP 1.0±0.1 1.1±0.1 0.8±0.1 0.9±0.1 
 C-P 1.0±0.3 0.7±0.0 0.6±0.2 0.5±0.1 
 M-NP 1.0±0.2 1.0±0.2 0.8±0.1 0.8±1.1 
 M-P 1.1±0.4 1.5±0.4 0.9±0.3 1.0±0.3 
ENaC-β C-NP 1.0±0.2 1.9±0.1 0.9±0.2 1.0±0.3 
 C-P 1.3±0.7 0.9±0.3 0.5±0.1 0.4±0.1 
 M-NP 1.0±0.3 0.9±0.2 0.7±0.2 0.7±0.3 
 M-P 0.7±0.1 0.7±0.1 0.4±0.2 0.4±0.1 
ENaC-γ C-NP 1.0±0.3 1.7±0.1 0.9±0.2 0.7±0.2 
 C-P 0.8±0.4 0.6±0.3 0.3±0.1 0.2±0.1 
 M-NP 1.0±0.3 0.8±0.4 0.7±0.2 0.8±0.3 
 M-P 0.7±0.3 1.0±0.1 0.6±0.4 0.4±0.1 
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To figures 6A-C 
Protein expression [% of β-actin] 
  NS HS LS HS/LS 
ENaC-α full C-NP   100± 30   70±10  100±10  280± 40 
 C-P   330± 90  210±10  190±10  510± 10 
 M-NP   110± 30  110±10  120±20  140± 60 
 M-P    40± 40  110±30  100±10  220± 50 
ENaC-α cleaved C-NP   100± 30  100±10  170±10  520± 30 
 C-P   420± 40  210±20  200±30  220± 10 
 M-NP   110±100  110±90  320±20  660± 30 
 M-P   700± 50  670±50 2100±30 1600± 50 
ENaC-β full C-NP   100± 40  110±10   70±20  100± 30 
 C-P   110± 20  100±20  120±20  190± 20 
 M-NP   100± 30  100±30  110±50  120±100 
 M-P   210± 50  360±10  450±40  520± 30 
ENaC-γ full C-NP   100± 10  110±20  120±30   80± 20 
 C-P    80± 40   80±20   50±50   70± 30 
 M-NP   110± 40   90±10  120±20  100± 20 
 M-P    70± 70  380±20  460±20  240± 60 
ENaC-γ cleaved C-NP   100± 10  100±10  170±20 7100± 10 
 C-P 10500± 10  350±80   80±10  170± 50 
 M-NP   110± 30   70±10  110±30   90± 50 
 M-P    40± 40   70±10   90±60   50± 50 
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